Accelerate your psychiatry trials with Elligo Health Research®. Our network of specialized Healthcare-First psychiatry research sites is dedicated to advancing psychiatric care through cutting-edge clinical studies. With 107% enrollment in ADHD trials and a rapid 20-day average start-up time, we’re reshaping the landscape of psychiatry clinical research.
Expertise in Psychiatry Studies
Elligo’s approach to psychiatry trials is as multifaceted as the human mind itself. Our sites are equipped to conduct a wide array of mental health studies, ensuring your research benefits from our depth of experience and specialized knowledge.
Specializations include:
- Major Depression (MDD)
- Treatment Resistant Depression
- Post-Partum Depression
- Other Sub-types of Depression
- PTSD
- ADHD
- Generalized Anxiety
- Social Anxiety
- Other Common Anxiety Disorders
- Smoking Cessation
- Fibromyalgia
- And more!